BioNTech SE (BNTX)
NASDAQ:BNTX

BioNTech SE Stock Price & Analysis

3,712 Followers

BNTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$117.08 - $309.99
Previous Close$161.62
Volume1.17M
Average Volume (3M)898.99K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€13.43B
Total Debt (Recent Filing)€274.00M
Price to Earnings (P/E)3.5
Beta1.92
Next EarningsMar 29, 2023
Dividend Yield1.53 (―)
EPS (TTM)46.73
Shares Outstanding242,685,401
R-Squared0.00116
Standard Deviation0.27
10 Day Avg. Volume883,770
30 Day Avg. Volume898,990
Price to Book (P/B)2.26
Price to Sales (P/S)1.98
Price to Cash Flow (P/CF)3.30
P/FCF Ratio3.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside26.15% Upside
Rating ConsensusModerate Buy
Alpha0.09
Number of Analyst Covering8


Financials


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BNTX FAQ

What was BioNTech SE’s price range in the past 12 months?
BioNTech SE lowest stock price was $117.08 and its highest was $309.99 in the past 12 months.
    What is BioNTech SE’s market cap?
    Currently, no data Available
    When is BioNTech SE’s upcoming earnings report date?
    BioNTech SE’s upcoming earnings report date is Mar 29, 2023 which is in 112 days.
      How were BioNTech SE’s earnings last quarter?
      BioNTech SE released its earnings results on Nov 07, 2022. The company reported $7.31 earnings per share for the quarter, beating the consensus estimate of $3.582 by $3.728.
        Is BioNTech SE overvalued?
        According to Wall Street analysts BioNTech SE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does BioNTech SE pay dividends?
          BioNTech SE pays a Notavailable dividend of $1.53 which represents an annual dividend yield of N/A. BioNTech SE’s last Notavailable dividend payment was on Jun 17, 2022. BioNTech SE’s upcoming ex-dividend date is Jun 02, 2022
            What is BioNTech SE’s EPS estimate?
            BioNTech SE’s EPS estimate is $7.75.
              How many shares outstanding does BioNTech SE have?
              BioNTech SE has 243,019,210 shares outstanding.
                What happened to BioNTech SE’s price movement after its last earnings report?
                BioNTech SE reported an EPS of $7.31 in its last earnings report, beating expectations of $3.582. Following the earnings report the stock price went up 4.154%.
                  Which hedge fund is a major shareholder of BioNTech SE?
                  Among the largest hedge funds holding BioNTech SE’s share is PRIMECAP Management Co. It holds BioNTech SE’s shares valued at 566M.

                    ---

                    BioNTech SE Stock Smart Score

                    The BioNTech SE stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    BioNTech SE

                    BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and autoimmune disorders.

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    CureVac
                    Formycon AG
                    Immatics
                    Affimed

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis